鉄欠乏性貧血治療の世界市場レポート (2025年)

鉄欠乏性貧血治療の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.1％で145億4,000万米ドルに成長します。予測期間の成長は、研究開発投資の増加、妊娠に伴うリスクの上昇、栄養不足の深刻化、ヘルスケア意識の高まり、鉄欠乏性貧血の継続的な流行など、いくつかの要因に起因すると考えられます。予測期間中に注目すべき主な動向としては、ウェアラブルヘモグロビンモニターの開発、患者チャットボットによるサポート、鉄吸収促進剤の導入、遠隔モニタリングプラットフォームの拡大、神経認知モニタリングの進展などが挙げられます。

慢性腎臓病（CKD）の有病率の増加は、鉄欠乏性貧血治療市場の拡大を促進すると予想されます。CKDは、時間の経過とともに腎臓の機能が徐々に低下していくもので、その増加は糖尿病罹患率の増加と関連している可能性があります。高血糖状態が長期間続くと、腎臓の血管にダメージを与え、老廃物を濾過する機能が損なわれます。鉄欠乏性貧血治療は、組織への酸素供給を改善し、疲労を軽減し、生活の質を高めるのに役立ちます。さらに、CKDにおけるエリスロポエチン産生の減少によってしばしば引き起こされる貧血に対処することで、腎機能を助ける可能性があります。アストラゼネカが2024年4月に発表した報告書によると、2032年までに米国、ブラジル、英国、スペイン、ドイツ、オランダ、中国、オーストラリアを含む8カ国で慢性腎臓病が人口の16.5％まで罹患し、進行期の患者は59.3％まで増加すると予測されています。このようなCKDの有病率の増加が、鉄欠乏性貧血治療に対する需要を促進しています。

鉄欠乏性貧血治療市場の主要企業は、治療効果、安全性、患者の利便性を向上させるため、鉄剤注射などの次世代ソリューションの開発に注力しています。鉄剤注射は、鉄欠乏症や鉄欠乏性貧血の治療において大きな進歩を示す、新規または大幅に強化された注射鉄剤治療を指します。例えば、2024年3月、インドに本社を置くカディラ・ファーマシューティカルズ社は、鉄欠乏性貧血（IDA）の治療にカルボキシマルトース第二鉄を使用する静脈注射鉄療法、レッドショットFCMを発表しました。この治療法は、カルボキシマルトース第二鉄製剤による迅速な鉄補給、アナフィラキシーのリスクの低さ、高用量の単回注入投与による迅速な補正、小児（1歳以上）および成人患者への適用可能性など、いくつかの主要な利点を提供します。ヘモグロビンの回復を促進し、妊婦やがん患者などのハイリスクグループに特に有効で、忍容性に優れています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の鉄欠乏性貧血治療市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の鉄欠乏性貧血治療市場：成長率分析
• 世界の鉄欠乏性貧血治療の市場規模・成長率：実績値、2019～2024年
• 世界の鉄欠乏性貧血治療の市場規模・成長率：予測値、2024～2029年、2034年
• 世界の鉄欠乏性貧血治療市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界の鉄欠乏性貧血治療市場：治療の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 医薬品
• 輸血
• その他の種類の治療
• 世界の鉄欠乏性貧血治療市場：薬剤の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 硫酸第一鉄
• グルコン酸第一鉄
• フマル酸第一鉄
• 水酸化鉄(III)
• グルコン酸鉄ナトリウム
• 鉄炭水化物
• その他の薬物の種類
• 世界の鉄欠乏性貧血治療市場：治療領域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 炎症性腸疾患
• 腎臓、産婦人科
• うっ血性心不全
• 腫瘍学
• その他の治療分野
• 世界の鉄欠乏性貧血治療市場：投与経路別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 経口剤
• 注射剤
• 世界の鉄欠乏性貧血治療市場：エンドユーザー別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 在宅医療
• 薬局
• 世界の鉄欠乏性貧血治療市場：医薬品タイプのサブセグメンテーション、タイプ別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 経口鉄サプリメント
• 静脈内鉄療法
• 鉄剤注射
• 赤血球造血刺激因子
• 世界の鉄欠乏性貧血治療市場：輸血タイプのサブセグメンテーション、タイプ別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 濃厚赤血球輸血
• 全血輸血
• 世界の鉄欠乏性貧血治療市場：その他の医療タイプのサブセグメンテーション、タイプ別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 食生活の変更
• 鉄注入療法
• 骨髄刺激

第7章 地域別・国別の分析

• 世界の鉄欠乏性貧血治療市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界の鉄欠乏性貧血治療市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 鉄欠乏性貧血治療市場：競合情勢
• 鉄欠乏性貧血治療市場：企業プロファイル
  • Sanofi SA（概要、製品・サービス、戦略、財務分析）
  • Fresenius SE & Co. KGaA（概要、製品・サービス、戦略、財務分析）
  • Amgen Inc.（概要、製品・サービス、戦略、財務分析）
  • Teva Pharmaceutical Industries Ltd.（概要、製品・サービス、戦略、財務分析）
  • Sandoz Group AG（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Daiichi Sankyo Company Limited
• Lupin Limited
• Zydus Lifesciences Limited
• Alkem Laboratories
• Pharmascience Inc.
• American Regent Inc.
• PharmaNutra S.p.A.
• Rockwell Medical Inc.
• Keryx Biopharmaceuticals Inc.
• Akebia Therapeutics Inc.
• Pharmacosmos A/S
• Pieris Pharmaceuticals Inc.
• AdvaCare Pharma USA LLC
• Apotex Inc.
• Shield Therapeutics plc

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• 鉄欠乏性貧血治療市場：最新機会を提供する国（2029年）
• 鉄欠乏性貧血治療市場：最新機会を提供する部門（2029年）
• 鉄欠乏性貧血治療市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Iron deficiency anemia treatment encompasses the medical strategies and interventions designed to correct iron deficiency in the body. These treatments aim to replenish iron levels through iron supplements, dietary changes, or intravenous iron, addressing the underlying cause of the deficiency and relieving associated symptoms.

The main types of iron deficiency anemia treatment include medications, blood transfusions, and other therapies. Medications refer to drugs or substances used to treat, prevent, or manage conditions including iron deficiency anemia. These include various types of iron supplements such as ferrous sulfate, ferrous gluconate, ferrous fumarate, ferric hydroxide, sodium ferric gluconate, and iron carbohydrates. These treatments are used across different therapy areas such as inflammatory bowel disease, renal disorders, obstetrics and gynecology, congestive heart failure, oncology, and more. The treatments can be administered orally or via injection and are utilized in various settings, including hospitals, clinics, home care environments, and pharmacies.

The iron deficiency anemia treatment market research report is one of a series of new reports from The Business Research Company that provides iron deficiency anemia treatment market statistics, including iron deficiency anemia treatment industry global market size, regional shares, competitors with a iron deficiency anemia treatment market share, iron deficiency anemia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the iron deficiency anemia treatment industry. This iron deficiency anemia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iron deficiency anemia treatment market size has grown rapidly in recent years. It will grow from $7.85 billion in 2024 to $8.89 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historic period can be attributed to several factors, including the expansion of awareness programs and initiatives, the aging baby boomer population, increasing nutritional deficiencies, a rise in anemia cases worldwide, and the growing number of women of reproductive age.

The iron deficiency anemia treatment market size is expected to see rapid growth in the next few years. It will grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The projected growth in the forecast period can be attributed to several factors, including increased investments in research and development, rising risks associated with pregnancy, growing nutritional deficits, heightened healthcare awareness, and the continued prevalence of iron deficiency anemia. Key trends to watch in the forecast period include the development of wearable hemoglobin monitors, the use of patient chatbots for support, the introduction of iron absorption enhancers, the expansion of remote monitoring platforms, and advancements in neurocognitive monitoring.

The growing prevalence of chronic kidney disease (CKD) is expected to drive the expansion of the iron deficiency anemia treatment market. CKD involves the gradual decline of kidney function over time, and its rise can be linked to increasing diabetes rates. High blood sugar levels over extended periods can damage the kidneys' blood vessels, impairing their ability to filter waste. Iron deficiency anemia treatment can help improve oxygen delivery to tissues, reduce fatigue, and enhance quality of life. Additionally, it may aid kidney function by addressing anemia, which is often caused by reduced erythropoietin production in CKD. A report published by AstraZeneca in April 2024 forecasts that by 2032, chronic kidney disease will affect up to 16.5 percent of the population in eight countries including the United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia, with advanced stage cases expected to rise by up to 59.3 percent. This growing prevalence of CKD is fueling the demand for iron deficiency anemia treatments.

Leading companies in the iron deficiency anemia treatment market are focusing on the development of next-generation solutions, such as iron injections, to improve treatment effectiveness, safety, and patient convenience. Iron injection refers to a new or significantly enhanced injectable iron therapy, marking a significant advancement in the treatment of iron deficiency and iron deficiency anemia. For example, in March 2024, Cadila Pharmaceuticals, an India-based company, introduced Redshot FCM, an intravenous iron therapy that uses ferric carboxymaltose to treat iron deficiency anemia (IDA). This therapy offers several key benefits, including an advanced ferric carboxymaltose formulation for fast iron replenishment, low risk of anaphylaxis, high-dose single-infusion administration for quick correction, and applicability for both pediatric (ages 1 and above) and adult patients. It helps accelerate hemoglobin recovery and is particularly beneficial for high-risk groups, such as pregnant women and cancer patients, with superior tolerability.

In August 2022, CSL Limited, an Australia-based biotechnology company specializing in iron deficiency injectables, acquired Vifor Pharma for an undisclosed amount. This acquisition strengthens CSL's commitment to patient care and enhances its capacity to offer innovative treatments. Vifor Pharma is a Switzerland-based provider of intravenous iron therapies for treating iron deficiency anemia.

Major players in the iron deficiency anemia treatment market are Sanofi SA, Fresenius SE & Co. KGaA, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories, Pharmascience Inc., American Regent Inc., PharmaNutra S.p.A., Rockwell Medical Inc., Keryx Biopharmaceuticals Inc., Akebia Therapeutics Inc., Pharmacosmos A/S, Pieris Pharmaceuticals Inc., AdvaCare Pharma USA LLC, Apotex Inc., and Shield Therapeutics plc.

North America was the largest region in the iron deficiency anemia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in iron deficiency anemia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iron deficiency anemia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The iron deficiency anemia treatment market consists of revenues earned by entities by providing services such as dietary counseling, monitoring and follow-up care, customized treatment plans, and management of side effects. The market value includes the value of related goods sold by the service provider or included within the service offering. The iron deficiency anemia treatment market also includes sales of iron-fortified foods, iron infusion kits, liquid iron supplements, and iron-rich multivitamins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iron Deficiency Anemia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iron deficiency anemia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for iron deficiency anemia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The iron deficiency anemia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Medications; Blood Transfusions; Other Treatment Types
• 2) By Drug Type: Ferrous Sulfate; Iron Carbohydrates; Other Drug Types
• 3) By Therapy Areas: Inflammatory Bowel Disease; Oncology; Other Therapy Areas
• 4) By Route Of Administration: Oral; Injectable
• 5) By End User: Hospitals; Clinics; Home Care Settings; Pharmacies
• Subsegments:
• 1) By Medications: Oral Iron Supplements; Intravenous Iron Therapy; Iron-Based Injections; Erythropoiesis-Stimulating Agents
• 2) By Blood Transfusions: Packed Red Blood Cells Transfusion; Whole Blood Transfusion
• 3) By Other Treatment Types: Dietary Modifications; Iron Infusion Therapy; Bone Marrow Stimulation
• Companies Mentioned: Sanofi SA; Fresenius SE & Co. KGaA; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Sandoz Group AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Iron Deficiency Anemia Treatment Market Characteristics

3. Iron Deficiency Anemia Treatment Market Trends And Strategies

4. Iron Deficiency Anemia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Iron Deficiency Anemia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Iron Deficiency Anemia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Iron Deficiency Anemia Treatment Market Growth Rate Analysis
• 5.4. Global Iron Deficiency Anemia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Iron Deficiency Anemia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Iron Deficiency Anemia Treatment Total Addressable Market (TAM)

6. Iron Deficiency Anemia Treatment Market Segmentation

• 6.1. Global Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Blood Transfusions
• Other Treatment Types
• 6.2. Global Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ferrous Sulfate
• Ferrous Gluconate
• Ferrous Fumerate
• Ferric Hydroxide
• Sodium Ferric Gluconate
• Iron Carbohydrates
• Other Drug Types
• 6.3. Global Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Bowel Disease
• Renal, Obstetrics and Gynecology
• Congestive Heart Failure
• Oncology
• Other Therapy Areas
• 6.4. Global Iron Deficiency Anemia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.5. Global Iron Deficiency Anemia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Care Settings
• Pharmacies
• 6.6. Global Iron Deficiency Anemia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Iron Supplements
• Intravenous Iron Therapy
• Iron-Based Injections
• Erythropoiesis-Stimulating Agents
• 6.7. Global Iron Deficiency Anemia Treatment Market, Sub-Segmentation Of Blood Transfusions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Packed Red Blood Cells Transfusion
• Whole Blood Transfusion
• 6.8. Global Iron Deficiency Anemia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dietary Modifications
• Iron Infusion Therapy
• Bone Marrow Stimulation

7. Iron Deficiency Anemia Treatment Market Regional And Country Analysis

• 7.1. Global Iron Deficiency Anemia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Iron Deficiency Anemia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Iron Deficiency Anemia Treatment Market

• 8.1. Asia-Pacific Iron Deficiency Anemia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Iron Deficiency Anemia Treatment Market

• 9.1. China Iron Deficiency Anemia Treatment Market Overview
• 9.2. China Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Iron Deficiency Anemia Treatment Market

• 10.1. India Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Iron Deficiency Anemia Treatment Market

• 11.1. Japan Iron Deficiency Anemia Treatment Market Overview
• 11.2. Japan Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Iron Deficiency Anemia Treatment Market

• 12.1. Australia Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Iron Deficiency Anemia Treatment Market

• 13.1. Indonesia Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Iron Deficiency Anemia Treatment Market

• 14.1. South Korea Iron Deficiency Anemia Treatment Market Overview
• 14.2. South Korea Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Iron Deficiency Anemia Treatment Market

• 15.1. Western Europe Iron Deficiency Anemia Treatment Market Overview
• 15.2. Western Europe Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Iron Deficiency Anemia Treatment Market

• 16.1. UK Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Iron Deficiency Anemia Treatment Market

• 17.1. Germany Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Iron Deficiency Anemia Treatment Market

• 18.1. France Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Iron Deficiency Anemia Treatment Market

• 19.1. Italy Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Iron Deficiency Anemia Treatment Market

• 20.1. Spain Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Iron Deficiency Anemia Treatment Market

• 21.1. Eastern Europe Iron Deficiency Anemia Treatment Market Overview
• 21.2. Eastern Europe Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Iron Deficiency Anemia Treatment Market

• 22.1. Russia Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Iron Deficiency Anemia Treatment Market

• 23.1. North America Iron Deficiency Anemia Treatment Market Overview
• 23.2. North America Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Iron Deficiency Anemia Treatment Market

• 24.1. USA Iron Deficiency Anemia Treatment Market Overview
• 24.2. USA Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Iron Deficiency Anemia Treatment Market

• 25.1. Canada Iron Deficiency Anemia Treatment Market Overview
• 25.2. Canada Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Iron Deficiency Anemia Treatment Market

• 26.1. South America Iron Deficiency Anemia Treatment Market Overview
• 26.2. South America Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Iron Deficiency Anemia Treatment Market

• 27.1. Brazil Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Iron Deficiency Anemia Treatment Market

• 28.1. Middle East Iron Deficiency Anemia Treatment Market Overview
• 28.2. Middle East Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Iron Deficiency Anemia Treatment Market

• 29.1. Africa Iron Deficiency Anemia Treatment Market Overview
• 29.2. Africa Iron Deficiency Anemia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Iron Deficiency Anemia Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Iron Deficiency Anemia Treatment Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Iron Deficiency Anemia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Iron Deficiency Anemia Treatment Market Competitive Landscape
• 30.2. Iron Deficiency Anemia Treatment Market Company Profiles
  • 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sandoz Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Iron Deficiency Anemia Treatment Market Other Major And Innovative Companies

• 31.1. Daiichi Sankyo Company Limited
• 31.2. Lupin Limited
• 31.3. Zydus Lifesciences Limited
• 31.4. Alkem Laboratories
• 31.5. Pharmascience Inc.
• 31.6. American Regent Inc.
• 31.7. PharmaNutra S.p.A.
• 31.8. Rockwell Medical Inc.
• 31.9. Keryx Biopharmaceuticals Inc.
• 31.10. Akebia Therapeutics Inc.
• 31.11. Pharmacosmos A/S
• 31.12. Pieris Pharmaceuticals Inc.
• 31.13. AdvaCare Pharma USA LLC
• 31.14. Apotex Inc.
• 31.15. Shield Therapeutics plc

32. Global Iron Deficiency Anemia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Iron Deficiency Anemia Treatment Market

34. Recent Developments In The Iron Deficiency Anemia Treatment Market

35. Iron Deficiency Anemia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Iron Deficiency Anemia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Iron Deficiency Anemia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Iron Deficiency Anemia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer